Revenue: The sum of all revenue fields included for a company's operating activities.
Arrowhead Pharmaceuticals, Inc. (ARWR) had Revenue of $542.71M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$542.71M |
$370.44M |
|
-- |
|
$542.71M |
|
$161.51M |
|
$381.20M |
|
$-11.59M |
|
$369.62M |
|
$369.62M |
|
$367.86M |
|
$367.86M |
|
$367.86M |
|
$367.86M |
|
$381.20M |
|
$390.20M |
|
133.36M |
|
134.48M |
|
$2.78 |
|
$2.75 |
|
| Balance Sheet Financials | |
$1.14B |
|
$384.80M |
|
$438.28M |
|
$1.57B |
|
$220.54M |
|
$208.93M |
|
$668.73M |
|
$889.27M |
|
$684.23M |
|
$676.51M |
|
$684.23M |
|
138.06M |
|
| Cash Flow Statement Financials | |
$313.78M |
|
$-343.30M |
|
$113.02M |
|
$102.69M |
|
$185.71M |
|
$83.02M |
|
$31.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.15 |
|
-- |
|
-- |
|
0.23 |
|
0.40 |
|
100.00% |
|
70.24% |
|
70.24% |
|
-- |
|
68.11% |
|
68.26% |
|
$300.97M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
-- |
|
229.48 |
|
0.39 |
|
53.76% |
|
54.38% |
|
23.38% |
|
41.19% |
|
$4.96 |
|
$2.24 |
|
$2.33 |
|